2021
DOI: 10.1016/j.biopha.2021.112283
|View full text |Cite
|
Sign up to set email alerts
|

REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 39 publications
0
8
0
Order By: Relevance
“…SR9009, a synthetic REV-ERBα agonist, suppressed γδT17 cells in vitro and in vivo. Topical application of SR9009 reduced the in ammatory symptoms of psoriatic dermatitis in mice [42]. NFIL3 has been reported as the intermediate gene between REV-ERBα and RORγt, thus linking the circadian clock to Th17 cell development.…”
Section: Discussionmentioning
confidence: 99%
“…SR9009, a synthetic REV-ERBα agonist, suppressed γδT17 cells in vitro and in vivo. Topical application of SR9009 reduced the in ammatory symptoms of psoriatic dermatitis in mice [42]. NFIL3 has been reported as the intermediate gene between REV-ERBα and RORγt, thus linking the circadian clock to Th17 cell development.…”
Section: Discussionmentioning
confidence: 99%
“…These processes finally cause neointimal hyperplasia. 3 Previous reports demonstrated a negative role of NR1D1 in the proliferation and migration of several cell lines, including pulmonary adenoma cells, 21 keratinocytes, 22 and glioblastoma cells. 23 This study further confirmed the negative regulatory role of NR1D1 in proliferation and migration of VSMCs.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, treatment with REV-ERBα agonist SR9009 could suppress the inflammatory effects in rheumatoid arthritis [ 30 ]. SR9009 can repress the γδT17 cells and attenuate the inflammatory symptoms, even when applied topically in the psoriasiform model [ 49 ]. REV-ERBs are negative regulators of BMAL1; hence, the repression of rev-erbα can positively affect the expression of bmal1 , as can be seen with the TNFα modulation ( Figure 3 G) [ 50 ].…”
Section: Discussionmentioning
confidence: 99%